RT

RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

Develops and produces IVD kits and biological pharmaceuticals for the healthcare sector.

RTALB | IS

Overview

Corporate Details

ISIN(s):
TRERTAL00018
LEI:
Country:
Türkiye
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

RTA Laboratuvarları, established in 1996, is a biotechnology company specializing in the research, development, and production of in-vitro diagnostic (IVD) products and biological pharmaceuticals. The company focuses on the fields of molecular biology and microbiology, utilizing its advanced R&D laboratories and expert personnel to develop a wide range of diagnostic kits and related biological materials. Its core activities include the production and distribution of domestic diagnostic solutions for the healthcare sector, with specific product lines in molecular biology, microbiology, and COVID-19 diagnostics. The company is committed to innovation and development in the molecular biotechnology field.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-27 16:10
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.09.2025)
Turkish 21.9 KB
2025-10-27 16:10
Quarterly Report
Faaliyet Raporu (30.09.2025)
Turkish 848.8 KB
2025-10-27 16:10
Report Publication Announcement
Faaliyet Raporu (30.09.2025)
Turkish 11.2 KB
2025-10-27 16:10
Quarterly Report
Financial Report
Turkish 1.9 MB
2025-10-27 16:10
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-08-11 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 52.9 KB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.06.2025)
Turkish 21.9 KB
2025-08-08 18:55
Interim Report
Faaliyet Raporu (30.06.2025)
Turkish 902.6 KB
2025-08-08 18:55
Report Publication Announcement
Faaliyet Raporu (30.06.2025)
Turkish 11.2 KB
2025-08-08 18:55
Interim Report
Financial Report
Turkish 1.9 MB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-07-07 11:10
Post-Annual General Meeting Information
2025 Yılı Bağımsız Denetim Şirketi Seçiminin Tescili ve İlanı
Turkish 29.4 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 414.9 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 672.0 KB
2025-07-07 11:08
Pre-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 14.5 KB

Automate Your Workflow. Get a real-time feed of all RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

STADA Arzneimittel AG Logo
A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.
Germany
SAZ
Stayble Therapeutics AB Logo
Develops an injectable drug for lumbar disc herniation pain as an alternative to surgery.
Sweden
STABL
STCUBE Logo
Develops first-in-class immunotherapies targeting BTN1A1 for treatment-resistant cancers.
South Korea
052020
STELLA PHARMA CORPORATION Logo
Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.
Japan
4888
StemRIM Inc. Logo
Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.
Japan
4599
STENOCARE A/S Logo
Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.
Denmark
STENO
Stoke Therapeutics, Inc. Logo
Developing RNA-based medicines for genetic diseases by increasing protein from the healthy gene.
United States of America
STOK
ST PHARM CO., LTD. Logo
A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.
South Korea
237690
Structure Therapeutics Inc. Logo
Develops oral small molecule drugs for chronic conditions like metabolic diseases and obesity.
United States of America
GPCR
Sugentech, Inc. Logo
Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.
South Korea
253840

Talk to a Data Expert

Have a question? We'll get back to you promptly.